Beam Therapeutics Inc. (BEAM)
NASDAQ · Healthcare
Beam Therapeutics Inc. Revenue 2019–2025
Beam Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Beam Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 31.7 M, a 324.87% increase year-over-year.
- Beam Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 57.4 M, a 13.28% increase year-over-year.
- Beam Therapeutics Inc. annual revenue for 2025 was 139.7 M, a 120.01% increase from 2024.
- Beam Therapeutics Inc. annual revenue for 2024 was 63.5 M, a 83.18% decrease from 2023.
- Beam Therapeutics Inc. annual revenue for 2023 was 377.7 M, a 520.01% increase from 2022.
- Beam Therapeutics Inc. annual revenue for 2022 was 60.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Beam Therapeutics Inc. Revenue — FAQ
Beam Therapeutics Inc. (BEAM) revenue over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Beam Therapeutics Inc.'s revenue?
Beam Therapeutics Inc. (BEAM) reported revenue of $140M for fiscal 2025.
Where can I see BEAM's revenue history?
The chart and table above show Beam Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.